JBIO Jade Biosciences, Inc. - Common Stock
NASDAQ · Biotechnology · Lihat di SEC EDGAR ↗ 10-K/10-Q Agu 10, 2026
$14,59
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$8,36rendah 52m
$28,00tinggi 52m
Kapitalisasi Pasar (MRQ)
$927M
P/E
-4.6
EPS
$-3.19
lencana Anda
Rentang 52M
$8–$28
Peringkat Analis
STRONG BUY
Target Harga
$50
P/E
-4.6
ROE
-47.7%
Margin Laba Bersih
·
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
JBIO Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$14.59
Kapitalisasi Pasar (MRQ)
$927M
P/E
-4.6
EPS
$-3.19
ROE
-47.7%
Rentang 52M
$8–$28
JBIO Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Pemecahan saham
| Tanggal ex-dividen | Pemecahan | Tipe |
|---|---|---|
| 29 April 2025 | 1-for-35 | Terbalik |
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
EPS$-3.192021-12-31 → 2025-12-31
Arus Kas Bebas$-95M2021-12-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | JBIO | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E | -4.6rata-rata 5T ≈-205.6 | ≈-205.6 | · | · | |
| P/B (MRQ) | 2.1rata-rata 5T ≈99.4 | ≈99.4 | 3.9 | Kurang nilai | |
| Price / FCF (Harga / FCF) | -7.6rata-rata 5T ≈-351.1 | ≈-351.1 | · | · | |
| Price / Cash Flow (Harga / Arus Kas) | -7.6rata-rata 5T ≈-289.8 | ≈-289.8 | · | · | |
| Price / Tangible Book (Harga / Nilai Buku Berwujud) | 2.2rata-rata 5T ≈115.4 | ≈115.4 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | JBIO | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| ROA | -60.3%rata-rata 5T ≈-48.7% | ≈-48.7% | -42.8% | Lemah | |
| ROE | -47.7%rata-rata 5T ≈-79.5% | ≈-79.5% | -29.7% | Lemah | |
| ROIC | -34.2%rata-rata 5T ≈-52.3% | ≈-52.3% | -56.1% | Tingkat teratas |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | JBIO | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 14.9rata-rata 5T ≈26.9 | ≈26.9 | 10.6 | Likuiditas kuat | |
| Quick Ratio (Rasio Cepat) | 20.3rata-rata 5T ≈26.0 | ≈26.0 | 8.2 | Likuiditas kuat |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Belum ada data untuk grup rasio ini
Data fundamental belum cukup untuk menghitung grup rasio ini.
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Dividen Yield, rasio pembayaran, riwayat dividen, CAGR 5 tahun
| Tanggal ex-dividen | Jumlah | Mata Uang | Imbal Hasil |
|---|---|---|---|
| Apr 29, 2025 | $2,40 | USD | ≈23.7% |
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-9.4%
Laporan Berikutnya
Nov 11, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 11, 2026 | $-0.76 | $-0.65 | -17.2% |
| 31 Maret 2026 | $-0.57 | $-0.49 | -15.8% | |
| 31 Des. 2025 | $-0.59 | $-0.48 | -22.0% | |
| 30 Sep. 2025 | $-0.48 | $-0.69 | 30.2% | |
| 30 Juni 2025 | $-0.86 | $-0.44 | -94.8% | |
| 31 Maret 2025 | $-3.15 | $-8.57 | 63.2% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $93M | $53M | $64M | $39M | $15M | $8M | |
| SG&A Expense | $20M | $21M | $17M | $15M | $8M | $949.0K | |
| Operating Expenses | $114M | $75M | $81M | $53M | $23M | $9M | |
| Operating Income | $-114M | $-75M | $-81M | $-53M | $-23M | $-9M | |
| Interest Expense | · | · | · | · | · | $75.0K | |
| Other Non-op | $-8.0K | $-19.0K | $-1.0K | $2M | $62.0K | $-722.0K | |
| Pretax Income | $-127M | $-70M | $-75M | $-51M | $-23M | $-10M | |
| Income Tax | $58.0K | $55.0K | $56.0K | $25.0K | $3.0K | · | |
| Net Income | $-127M | $-70M | $-76M | $-52M | $-23M | $-10M | |
| EPS (Basic) | $-3.19 | $-2.44 | $-2.87 | $-2.10 | $-1.87 | · | |
| EPS (Diluted) | $-3.19 | $-2.44 | $-2.87 | $-2.10 | $-1.87 | · | |
| Shares (Basic) | 31,359,958 | 28,582,194 | 26,331,630 | 24,472,104 | 12,293,629 | · | |
| Shares (Diluted) | 31,359,958 | 28,582,194 | 26,331,630 | 24,472,104 | 12,293,629 | · | |
| EBITDA | $-114M | $-75M | $-81M | $-53M | $-23M | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $88M | $69M | $23M | $22M | $54M | $5M | |
| Short-term Investments | $248M | $0 | $99M | $107M | $113M | · | |
| Prepaid Expense | $13M | $268.0K | $2M | $2M | $7M | $103.0K | |
| Current Assets | $349M | $70M | $124M | $131M | $174M | $5M | |
| PP&E (Net) | $170.0K | · | $288.0K | $242.0K | $186.0K | $39.0K | |
| PP&E (Gross) | · | · | · | · | · | $40.0K | |
| Accum. Depreciation | · | · | · | · | · | $1.0K | |
| Other Non-current Assets | $69.0K | $3M | $2M | $3M | $302.0K | · | |
| Total Assets | $350M | $73M | $127M | $135M | $175M | $5M | |
| Accounts Payable | $2M | $1M | $2M | $3M | $1M | $618.0K | |
| Accrued Liabilities | $9M | $4M | · | · | · | · | |
| Current Liabilities | $17M | $12M | $18M | $8M | $3M | $2M | |
| Capital Leases | $724.0K | $0 | $255.0K | $705.0K | $382.0K | · | |
| Total Liabilities | $17M | $120M | $18M | $9M | $3M | $2M | |
| Common Stock | $5.0K | $1.0K | $3.0K | $2.0K | $2.0K | · | |
| Paid-in Capital | $507M | $179.0K | $273M | $215M | $209M | $63.0K | |
| Retained Earnings | $-174M | $-47M | $-163M | $-88M | $-36M | $-13M | |
| AOCI | $129.0K | $0 | $237.0K | $-466.0K | $-59.0K | · | |
| Stockholders' Equity | $333M | $-47M | $109M | $127M | $172M | $-13M | |
| Liabilities + Equity | $350M | $73M | $127M | $135M | $175M | $5M | |
| Shares Outstanding | 49,316,287 | 3,672,794 | 27,762,703 | 24,722,974 | 24,410,393 | 243,076 |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $20M | $11M | $12M | $5M | $2M | $58.0K | |
| Deferred Tax | $-44.0K | · | · | · | · | · | |
| Operating Cash Flow | $-95M | $-71M | $-57M | $-39M | $-27M | $-8M | |
| CapEx | $196.0K | · | $142.0K | $195.0K | $181.0K | · | |
| Investing Cash Flow | $-247M | $56M | $12M | $7M | $-113M | · | |
| Stock Issued | · | $24M | $45M | · | $127M | · | |
| Net Stock Activity | · | $24M | $45M | · | $127M | · | |
| Financing Cash Flow | $361M | $25M | $46M | $396.0K | $190M | $9M | |
| Net Change in Cash | $19M | $10M | $1M | $-32M | $50M | $1M | |
| Free Cash Flow | $-95M | · | $-57M | $-39M | $-28M | · |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -60.3% | -67.0% | -57.5% | -33.2% | -25.5% | · | |
| ROE | -47.7% | -233.8% | -64.2% | -38.8% | -13.0% | · | |
| ROIC | -34.2% | -97.7% | -74.4% | -42.0% | -13.4% | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 21.1 | 20.9 | 7.0 | 16.9 | 68.4 | · | |
| Quick Ratio | 20.3 | 20.5 | 6.9 | 16.6 | 65.6 | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.74 | $2.64 | $3.94 | $5.13 | $7.06 | · | |
| Cash Flow / Share | $-3.02 | $-2.49 | $-2.16 | $-1.60 | · | · | |
| Cash / Share | $1.79 | $1.16 | $0.85 | $0.91 | $2.22 | · | |
| EPS (TTM) | $-3.19 | $-2.44 | $-2.87 | $-2.10 | $-1.87 | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-127M | $-70M | $-76M | $-52M | $-23M | · | |
| Market Cap | $761M | $2.69B | $21.99B | $25.35B | $10.07B | · | |
| P/E | -4.8 | -38.0 | -276.0 | -488.3 | -220.7 | · | |
| P/B | 2.3 | 35.2 | 200.9 | 200.0 | 58.4 | · | |
| P / Tangible Book | 2.3 | · | 200.9 | 200.0 | 58.4 | · | |
| P / Cash Flow | -8.0 | -37.8 | -387.3 | -648.1 | -367.6 | · | |
| P / FCF | -8.0 | · | -386.3 | -644.8 | -365.2 | · | |
| Earnings Yield | -20.7% | -2.6% | -0.36% | -0.20% | -0.45% | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $50M | $36M | $29M | $22M | $23M | $20M | $-2M | $14M | $21M | $20M | $18M | $17M | $16M | $13M | $12M | $11M | |
| SG&A Expense | $9M | $7M | $6M | $5M | $5M | $3M | $11M | $1M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $3M | |
| Operating Expenses | $59M | $43M | $55M | $27M | $28M | $23M | $9M | $15M | $26M | $25M | $22M | $21M | $20M | $18M | $16M | $14M | |
| Operating Income | $-59M | $-43M | $-55M | $-27M | $-28M | $-23M | $-9M | $-15M | $-26M | $-25M | $-22M | $-21M | $-20M | $-18M | $-16M | $-14M | |
| Other Non-op | $-62.0K | $-9.0K | $4M | $-28.0K | $0 | $0 | $-1M | $0 | $1M | $-3.0K | $-2M | $1.0K | $1M | $1M | $2M | $4.0K | |
| Pretax Income | $-56M | $-40M | · | · | $-32M | $-38M | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | $15.0K | $16.0K | $58.0K | $0 | $0 | · | · | $0 | · | · | · | · | · | · | · | · | |
| Net Income | $-56M | $-40M | $-32M | $-25M | $-32M | $-38M | $-5M | $-16M | $-25M | $-23M | $-20M | $-20M | $-19M | $-17M | $-15M | $-14M | |
| EPS (Basic) | $-0.76 | $-0.57 | $-1.76 | $-0.48 | $-0.86 | $-12.10 | $4.41 | $-5.16 | $-0.86 | $-0.83 | $-0.73 | $-0.71 | $-0.76 | $-0.67 | $-0.60 | $-0.56 | |
| EPS (Diluted) | $-0.76 | $-0.57 | $-1.76 | $-0.48 | $-0.86 | $-12.10 | $4.41 | $-5.16 | $-0.86 | $-0.83 | $-0.73 | $-0.71 | $-0.76 | $-0.67 | $-0.60 | $-0.56 | |
| Shares (Basic) | 61,050,775 | 57,777,165 | · | 39,584,489 | 28,431,158 | 3,155,500 | · | 3,155,500 | 28,756,043 | 27,795,827 | · | 27,640,542 | 25,166,505 | 24,777,847 | · | 24,454,786 | |
| Shares (Diluted) | 61,050,775 | 57,777,165 | · | 39,584,489 | 28,431,158 | 3,155,500 | · | 3,155,500 | 28,756,043 | 27,795,827 | · | 27,640,542 | 25,166,505 | 24,777,847 | · | 24,454,786 | |
| EBITDA | $-59M | $-43M | · | $-27M | $-28M | $-3M | · | $-17M | $-26M | $-25M | · | $-21M | $-20M | $-18M | · | $-14M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $107M | $55M | $88M | $50M | $221M | $44M | $34M | $31M | $31M | $9M | $23M | $32M | $61M | $27M | $22M | $22M | |
| Short-term Investments | $354M | $256M | $248M | $149M | · | $32M | $45M | $58M | $73M | $90M | $99M | $103M | $89M | $92M | $107M | $120M | |
| Prepaid Expense | $10M | $7M | $13M | $2M | $2M | $1M | $1M | $2M | $7M | $4M | $2M | $2M | $2M | $2M | $2M | $3M | |
| Current Assets | $471M | $319M | $349M | $201M | $223M | $77M | $80M | $91M | $111M | $103M | $124M | $138M | $152M | $121M | $131M | $145M | |
| PP&E (Net) | $144.0K | $157.0K | $170.0K | $176.0K | $147.0K | $2.0K | $6.0K | $14.0K | $232.0K | $260.0K | $288.0K | $316.0K | $245.0K | $267.0K | $242.0K | $330.0K | |
| Other Non-current Assets | $69.0K | $69.0K | $69.0K | $174.0K | $60.0K | · | · | $81.0K | $81.0K | $3M | $2M | $2M | $2M | $3M | $3M | $1M | |
| Total Assets | $472M | $319M | $350M | $202M | $224M | $78M | $80M | $91M | $112M | $107M | $127M | $141M | $156M | $124M | $135M | $148M | |
| Accounts Payable | $7M | $4M | $2M | $1M | $8M | $69.0K | $224.0K | $908.0K | $4M | $3M | $2M | $4M | $6M | $5M | $3M | $5M | |
| Accrued Liabilities | $15M | $15M | $9M | $14M | $8M | · | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $32M | $22M | $17M | $22M | $22M | $2M | $4M | $10M | $17M | $16M | $18M | $15M | $13M | $11M | $8M | $8M | |
| Capital Leases | $628.0K | $679.0K | $724.0K | $747.0K | $792.0K | · | · | $81.0K | $206.0K | $329.0K | $255.0K | $358.0K | $476.0K | $591.0K | $705.0K | $800.0K | |
| Total Liabilities | $32M | $23M | $17M | $23M | $22M | $2M | $4M | $10M | $17M | $16M | $18M | $15M | $14M | $11M | $9M | $9M | |
| Common Stock | $6.0K | $5.0K | $5.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $2.0K | $2.0K | $2.0K | |
| Paid-in Capital | $711M | $512M | $507M | $322M | $319M | $311M | $309M | $308M | $306M | $278M | $273M | $269M | $266M | $218M | $215M | $213M | |
| Retained Earnings | $-271M | $-215M | $-174M | $-142M | $-117M | $-236M | $-233M | $-228M | $-211M | $-187M | $-163M | $-143M | $-123M | $-104M | $-88M | $-73M | |
| AOCI | $-660.0K | $-342.0K | $129.0K | $29.0K | $-24.0K | $50.0K | $105.0K | $224.0K | $-83.0K | $-33.0K | $237.0K | $-195.0K | $-223.0K | $-201.0K | $-466.0K | $-771.0K | |
| Stockholders' Equity | $440M | $296M | $333M | $179M | $202M | $75M | $76M | $80M | $94M | $91M | $109M | $126M | $142M | $113M | $127M | $139M | |
| Liabilities + Equity | $472M | $319M | $350M | $202M | $224M | $78M | $80M | $91M | $112M | $107M | $127M | $141M | $156M | $124M | $135M | $148M | |
| Shares Outstanding | 63,556,065 | 49,345,967 | 49,316,287 | 32,626,730 | 32,626,730 | 28,985,019 | 28,985,019 | 28,867,711 | 28,854,750 | 27,898,761 | 27,762,703 | 27,653,187 | 27,601,098 | 24,816,940 | 24,722,974 | 24,506,390 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $14M | $7M | $11M | $4M | $4M | $2M | $3M | $27.0K | $4M | $4M | $3M | $3M | $3M | $2M | $2M | $1M | |
| Operating Cash Flow | $-44M | $-24M | $-34M | $-22M | $-37M | $-19M | $-11M | $-7M | $-20M | $-24M | $-15M | $-16M | $-15M | $-11M | $-15M | $-10M | |
| CapEx | · | · | $3.0K | $57.0K | · | · | · | · | · | · | $64.0K | $32.0K | $30.0K | $16.0K | $4.0K | $33.0K | |
| Investing Cash Flow | $-98M | $-8M | $-98M | $-149M | $-13M | $13M | $13M | $0 | $18M | $9M | $6M | $-13M | $4M | $15M | $14M | $5M | |
| Stock Issued | · | · | · | · | · | · | $307.0K | $0 | · | · | $0 | $0 | · | · | · | · | |
| Financing Cash Flow | $194M | $-795.0K | $170M | $0 | $191M | $-700.0K | $554.0K | $95M | $24M | $471.0K | $463.0K | $20.0K | $45M | $223.0K | $357.0K | $37.0K | |
| Net Change in Cash | $52M | $-33M | $38M | $-171M | $141M | $-19M | $3M | $88M | $22M | $-14M | $-9M | $-29M | $34M | $4M | $-22.0K | $-5M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | $-11M | · | · |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -16.0% | -20.3% | · | -17.2% | -19.1% | -2.7% | · | -14.0% | -18.5% | -20.1% | · | -13.6% | -12.2% | -11.3% | · | -8.2% | |
| ROE | -17.4% | -21.7% | · | -19.4% | -21.7% | -3.0% | · | -15.8% | -21.0% | -22.7% | · | -14.8% | -13.0% | -12.0% | · | -8.5% | |
| ROIC | -13.4% | -14.7% | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 14.9 | 14.3 | · | 9.0 | 10.3 | 32.0 | · | 8.8 | 6.5 | 6.7 | · | 9.3 | 11.5 | 11.3 | · | 18.8 | |
| Quick Ratio | 14.6 | 14.0 | · | 8.9 | 10.2 | 31.5 | · | 8.6 | 6.1 | 6.4 | · | 9.2 | 11.3 | 11.2 | · | 18.5 |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $6.92 | $6.01 | · | $5.50 | $6.18 | $2.59 | · | $2.79 | $3.27 | $3.26 | · | $4.55 | $5.14 | $4.56 | · | $5.68 | |
| Cash Flow / Share | · | $-0.42 | · | · | · | $-0.08 | · | · | · | $-0.85 | · | · | · | $-0.46 | · | · | |
| Cash / Share | $1.69 | $1.12 | · | $1.54 | $6.77 | $1.53 | · | $1.08 | $1.08 | $0.33 | · | $1.16 | $2.21 | $1.07 | · | $0.91 | |
| EPS (TTM) | $-3.57 | $-3.67 | · | $-9.03 | $-13.71 | $-13.71 | · | $-7.58 | $-3.13 | $-3.03 | · | $-2.74 | $-2.59 | $-2.32 | · | $-1.57 |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-153M | $-130M | · | $-101M | $-92M | $-85M | · | $-85M | $-88M | $-82M | · | $-70M | $-64M | $-57M | · | $-45M | |
| Market Cap | $1.41B | $693M | · | $282M | $326M | $2.55B | · | $2.11B | $1.68B | $28.87B | · | $13.13B | $16.57B | $17.52B | · | $14.22B | |
| P/E | -6.2 | -3.8 | · | -1.0 | -0.7 | -6.4 | · | -9.7 | -18.6 | -341.6 | · | -173.3 | -231.8 | -304.3 | · | -369.6 | |
| P/B | 3.2 | 2.3 | · | 1.6 | 1.6 | 33.9 | · | 26.2 | 17.8 | 317.6 | · | 104.5 | 116.7 | 154.9 | · | 102.2 | |
| P / Tangible Book | 3.2 | 2.3 | · | 1.6 | 1.6 | 33.9 | · | 26.2 | 17.8 | 317.6 | · | 104.5 | 116.7 | 154.9 | · | 102.2 | |
| P / Cash Flow | · | -28.8 | · | · | · | -1069.4 | · | · | · | -1219.7 | · | · | · | -1533.6 | · | · | |
| Earnings Yield | -16.1% | -26.1% | · | -104.6% | -137.2% | -15.6% | · | -10.4% | -5.4% | -0.29% | · | -0.58% | -0.43% | -0.33% | · | -0.27% |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Laba Bersih | $-127M | $-70M | $-76M | $-52M | $-23M |
| EPS Dilusian | $-3.19 | $-2.44 | $-2.87 | $-2.10 | $-1.87 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rasio Lancar | 21.1 | 20.9 | 7.0 | 16.9 | 68.4 |
| Rasio Cepat | 20.3 | 20.5 | 6.9 | 16.6 | 65.6 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-95M | · | $-57M | $-39M | $-28M |
Pemilik institusional (13F) 157 pengaju · $1.6B total · Per tanggal 30 Sep. 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
157
Nilai yang dipegang
$1.6B
Posisi baru
52
Posisi yang keluar
16
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 52 (+18 vs Kuartal sebelumnya) | 16 (+5 vs Kuartal sebelumnya) | 61 (+24 vs Kuartal sebelumnya) | 24 (-8 vs Kuartal sebelumnya) | +16.8M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| FMR LLC | $202.799.207 | 9.126.877 | 13,07% | Saham |
| Fairmount Funds Management LLC | $101.178.637 | 4.553.494 | 6,52% | Saham |
| RA CAPITAL MANAGEMENT, L.P. | $81.571.464 | 3.671.083 | 5,26% | Saham |
| Venrock Adviser, LLC | $71.556.488 | 3.220.364 | 4,61% | Saham |
| Bellevue Group AG | $67.948.671 | 3.057.996 | 4,38% | Saham |
| Paradigm Biocapital Advisors LP | $63.491.539 | 2.857.405 | 4,09% | Saham |
| BlackRock, Inc. | $62.248.241 | 2.801.451 | 4,01% | Saham |
| FRANKLIN RESOURCES INC | $62.040.028 | 2.792.080 | 4,00% | Saham |
| STATE STREET CORP | $51.890.033 | 2.335.285 | 3,34% | Saham |
| VANGUARD CAPITAL MANAGEMENT LLC | $49.878.856 | 2.244.773 | 3,21% | Saham |
| JANUS HENDERSON GROUP PLC | $43.557.008 | 3.105.669 | 2,81% | Saham |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $42.458.243 | 1.910.812 | 2,74% | Saham |
| Polar Capital Holdings Plc | $41.039.940 | 1.846.982 | 2,64% | Saham |
| Avidity Partners Management LP | $37.789.732 | 1.700.708 | 2,43% | Saham |
| Remedium Capital Partners, LLC | $35.057.605 | 1.577.750 | 2,26% | Saham |
| Soleus Capital Management, L.P. | $34.456.332 | 1.550.690 | 2,22% | Saham |
| JPMORGAN CHASE & CO | $32.613.997 | 1.475.079 | 2,10% | Saham |
| VANGUARD GROUP INC | $32.337.685 | 2.095.767 | 2,08% | Saham |
| BAKER BROS. ADVISORS LP | $27.340.066 | 1.230.426 | 1,76% | Saham |
| Logos Global Management LP | $24.997.500 | 1.125.000 | 1,61% | Saham |
| Versant Venture Management, LLC | $22.037.418 | 991.783 | 1,42% | Saham |
| ACORN CAPITAL ADVISORS, LLC | $21.925.807 | 986.760 | 1,41% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $21.896.658 | 985.178 | 1,41% | Saham |
| CITADEL ADVISORS LLC | $20.651.423 | 929.407 | 1,33% | Saham |
| Foresite Capital Management VI LLC | $19.701.741 | 886.667 | 1,27% | Saham |
| Balyasny Asset Management L.P. | $19.525.292 | 878.726 | 1,26% | Saham |
| Affinity Asset Advisors, LLC | $18.672.577 | 840.350 | 1,20% | Saham |
| SAMSARA BIOCAPITAL, LLC | $16.359.186 | 736.237 | 1,05% | Saham |
| GOLDMAN SACHS GROUP INC | $16.336.678 | 735.224 | 1,05% | Saham |
| Pictet Asset Management Holding SA | $16.304.325 | 733.768 | 1,05% | Saham |
| Aberdeen Group plc | $13.801.020 | 621.108 | 0,89% | Saham |
| MARSHALL WACE, LLP | $13.015.609 | 585.761 | 0,84% | Saham |
| BANK OF AMERICA CORP /DE/ | $10.820.140 | 486.955 | 0,70% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $10.255.152 | 461.528 | 0,66% | Saham |
| Blackstone Inc. | $9.672.810 | 435.320 | 0,62% | Saham |
| Ikarian Capital, LLC | $9.495.694 | 427.349 | 0,61% | Saham |
| Walleye Capital LLC | $8.116.344 | 365.272 | 0,52% | Saham |
| MILLENNIUM MANAGEMENT LLC | $6.989.257 | 314.548 | 0,45% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $6.774.145 | 304.867 | 0,44% | Saham |
| NORTHERN TRUST CORP | $6.556.700 | 295.081 | 0,42% | Saham |
| Connor, Clark & Lunn Investment Management Ltd. | $4.825.229 | 217.157 | 0,31% | Saham |
| BNP PARIBAS FINANCIAL MARKETS | $4.431.312 | 199.429 | 0,29% | Saham |
| Jump Financial, LLC | $3.838.439 | 172.747 | 0,25% | Saham |
| Point72 Asset Management, L.P. | $3.715.273 | 167.204 | 0,24% | Saham |
| Russell Investments Group, Ltd. | $3.623.746 | 163.084 | 0,23% | Saham |
| Opaleye Management Inc. | $3.221.900 | 145.000 | 0,21% | Saham |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $3.114.989 | 140.886 | 0,20% | Saham |
| UBS Group AG | $2.834.761 | 127.577 | 0,18% | Saham |
| MORGAN STANLEY | $2.766.679 | 124.513 | 0,18% | Saham |
| Quantinno Capital Management LP | $2.548.990 | 114.716 | 0,16% | Saham |
Aktivis & pemilik 5%+ 5 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Fairmount Funds Management LLC, Fairmount Healthcare Fund II L.P., Fairmount Healthcare Co-Invest IV L.P., Peter Evan Harwin, Tomas Kiselak ×3 pengajuan | 9 Juni 2026 | 19,99% | Amandemen | · | SEC |
| Sofinnova Venture Partners X, L.P. ("SVP X"), Sofinnova Management X, L.P. ("SM X LP"), Sofinnova Management X-A, L.L.C. ("SM X LLC"), Dr. James I. Healy ("Healy"), Dr. Maha Katabi ("Katabi") | 5 Maret 2026 | 0,30% | Amandemen | Investasi pasif | SEC |
| RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, RA Capital Healthcare Fund, L.P. ×5 pengajuan | 30 April 2025 | 4,10% | Amandemen | · | SEC |
| Atlas Venture Fund XII, L.P., Atlas Venture Associates XII, L.P., Atlas Venture Associates XII, LLC ×5 pengajuan | 30 April 2025 | 0,20% | Amandemen | M&A / penjualan | SEC |
| Sofinnova Venture Partners X, L.P. (“SVP X”), Sofinnova Management X, L.P. (“SM X LP”), Sofinnova Management X-A, L.L.C. (“SM X LLC”), Dr. James I. Healy (“Healy”), Dr. Maha Katabi (“Katabi”) ×3 pengajuan | 20 Feb. 2024 | · | Pengajuan awal | Investasi pasif | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 24 orang dalam · 11 pejabat · 14 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Tom Frohlich | Chief Executive Officer | 12 Feb. 2026 A | 86.331 | 0 | 0 | $0 |
| Timothy P Noyes | CHIEF EXECUTIVE OFFICER | 16 Mei 2024 M | 0 | 0 | 0 | $0 |
| Bradford D. Dahms | Chief Financial Officer | 12 Feb. 2026 A | 37.813 | 0 | 0 | $0 |
| George A Eldridge | Officer Title: Chief Financial Officer and Treasurer | 14 Juni 2024 M | 5.022 | 0 | 0 | $0 |
| Benjamin T Dake | Officer Title: President, Chief Operating Officer and Secretary | 1 Agu 2024 M | 14.252 | 0 | 0 | $0 |
| Elizabeth Balta | Chief Legal Officer and Corporate Secretary | 12 Feb. 2026 A | 28.125 | 0 | 0 | $0 |
| Andrew James King | Chief Scientific Officer & Head of Research and Development | 12 Feb. 2026 A | 386.113 | 0 | 0 | $0 |
| Marinus Verwijs | CHIEF TECHNICAL OFFICER | 14 Juni 2024 M | 0 | 0 | 0 | $0 |
| Hunter Gillies | CHIEF MEDICAL OFFICER | 13 Juni 2024 M | 5.602 | 0 | 0 | $0 |
| Ralph Niven | CHIEF SCIENTIFIC OFFICER | 5 Feb. 2024 M | 1.609 | 0 | 0 | $0 |
| Timothy Pigot | CHIEF COMMERCIAL OFFICER | 22 Jan. 2024 A | · | 0 | 0 | $0 |
| Mark Eisner | Direktur | 25 Juni 2026 A | · | 0 | 0 | $0 |
| Christopher W. Cain | Direktur | 9 Juni 2026 A | · | 0 | 0 | $0 |
| Lawrence Otto Klein | Direktur | 9 Juni 2026 A | · | 0 | 0 | $0 |
| Erin Lavelle | Direktur | 9 Juni 2026 A | · | 0 | 0 | $0 |
| Eric Dobmeier | Direktur | 9 Juni 2026 A | · | 0 | 0 | $0 |
| David S. Grayzel | Direktur | 5 Juni 2024 A | 14.502 | 0 | 0 | $0 |
| Dr. Maha Katabi | Direktur | 5 Juni 2024 A | 3.758.686 | 0 | 0 | $0 |
| Joshua Resnick | Direktur | 5 Juni 2024 A | · | 0 | 0 | $0 |
| Habib J Dable | Direktur | 5 Juni 2024 A | · | 0 | 0 | $0 |
| Allison Dorval | Direktur | 5 Juni 2024 A | · | 0 | 0 | $0 |
| Mark T Iwicki | Direktur | 5 Juni 2024 A | · | 0 | 0 | $0 |
| Donald J Santel | Direktur | 5 Juni 2024 A | · | 0 | 0 | $0 |
| Atlas Venture Fund XII, L.P. | Pemilik 10% | 15 Juli 2022 J | 2.327.909 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 19 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 0,86% | 20.261 NS | 31 Juli 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,21% | 52.113 NS | 31 Juli 2026 | N-PORT |
| IWC · iShares Trust | 0,15% | 110.135 SH | 11 Sep. 2026 | Harian |
| FFSM · FIDELITY COVINGTON TRUST | 0,12% | 93.021 NS | 31 Juli 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,12% | 111.509 SH | 19 Agu 2026 | Harian |
| PWS · Pacer Funds Trust | 0,06% | 712 NS | 31 Juli 2026 | N-PORT |
| IWO · iShares Trust | 0,04% | 305.709 SH | 11 Sep. 2026 | Harian |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,04% | 34.886 SH | 19 Agu 2026 | Harian |
| IWM · iShares Trust | 0,02% | 836.516 SH | 11 Sep. 2026 | Harian |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 187.416 SH | 19 Agu 2026 | Harian |
| FHLC · FIDELITY COVINGTON TRUST | 0,01% | 19.767 NS | 31 Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 489.225 SH | 19 Agu 2026 | Harian |
| VHT · VANGUARD WORLD FUND | 0,01% | 124.984 SH | 19 Agu 2026 | Harian |
| WSML · iShares Trust | 0,01% | 2.568 SH | 11 Sep. 2026 | Harian |
| ITOT · iShares Trust | 0,00% | 71.131 SH | 11 Sep. 2026 | Harian |
| IWV · iShares Trust | 0,00% | 15.055 SH | 9 Sep. 2026 | Harian |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.699.343 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2.733 SH | 19 Agu 2026 | Harian |
| ISCB · iShares Trust | · | 2.353 SH | 11 Sep. 2026 | Harian |
JBIO Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 17 analis
BELI
Target median
$47.00
+222,1%
8 47,1%
Beli Kuat
8 47,1%
Beli
1 5,9%
Tahan
0 0,0%
Jual
0 0,0%
Jual Kuat
Target Harga 12 Bulan
8 analis · 2026-10-23Target rata-rata $50.12 +243,6%
← Di bawah semua target
Harga saat ini $14.59
Rendah$40.00
Rata-rata$50.12
Tinggi$77.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| JBIO | $761M | -4.8 | · | · | -47.7% | · |
| REPL | $633M | -2.3 | · | · | -146.2% | · |
| JANX | $833M | -7.5 | -5.5% | -1136.2% | -11.7% | · |
| MNKD | $1.75B | 283.5 | 22.2% | 1.7% | -11.1% | · |
| AVBP | $854M | -4.7 | · | · | -59.7% | · |
| CGEM | $624M | -3.2 | · | · | -44.0% | · |
| GLUE | $1.03B | · | 63.5% | -31.2% | -15.4% | · |
| ODTX | · | · | · | · | · | · |
| RIGL | $784M | 2.2 | 64.1% | 124.7% | 155.1% | · |
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 10, 2026